Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical & Experimental Metastasis|June 11, 2008
The tumor microenvironment and metastatic diseaseSarah Jane Lunt, Naz Chaudary, Richard P HillFuture Oncology (London, England)|December 18, 2008
Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesisSarah Jane Lunt, Anthony Fyles, Richard P Hill, et al.BMC Cancer|May 30, 2008
Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer modelTuula M Kalliomäki, Gordon McCallum, Sarah Jane Lunt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic disseminationSarah Jane Lunt, Brian A Telfer, Richard J Fitzmaurice, et al.Journal of Biomedical Optics|March 10, 2010
Application of intravital microscopy in studies of tumor microcirculationSarah Jane Lunt, Colin Gray, Constantino Carlos Reyes-Aldasoro, et al.BMC Cancer|January 9, 2008
Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumoursSarah Jane Lunt, Tuula Mk Kalliomaki, Allison Brown, et al.Cancer Research|February 21, 2006
Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumorsJulia V Skliarenko, Sarah Jane Lunt, Maggie L Gordon, et al.Microvascular Research|January 12, 2008
Interstitial permeability and elasticity in human cervix cancerMichael Milosevic, Sarah Jane Lunt, Eric Leung, et al.International Journal of Cancer|December 15, 2010
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphateSarah Jane Lunt, Simon Akerman, Sally A Hill, et al.Cancer Research|April 6, 2017
Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in SarcomaWilliam R English, Sarah Jane Lunt, Matthew Fisher, et al.Pageof 2